Prices of 980 medications the Health Ministry is purchasing in a tender to supply public hospitals have increased by a margin of 20-50%, presumably as a result of the ministry’s decision in January to raise meds prices under pressure from the industry, Al Borsa reports. These price increases will not be passed on to consumers, and will instead be covered by the state under the national health insurance scheme, according to Central Administration of Pharmaceutical Affairs head Rasha Ziada.
More from Enterprise
How correspondent banking works, and what the FinCEN clampdown on Banque Misr UAE means for business
As FinCEN proposes cutting Banque Misr’s UAE branches from USD…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
EGX30 gained 2.79% in 3Q, but September gave back most of its July-August run, with mid-caps falling the hardest
Small- and mid-cap indices widened their lead over the benchmark…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…